Special Interest Groups (SIGs)

Special Interest Groups (SIGs)

BioMedical SIG

The objective of the SIG is to increase the translation of research results into solutions in human healthcare.

About BioMedical SIG

The objective of the SIG is to increase the translation of research results into solutions in human healthcare.

The aim of the SIG is to create a place to propose and discuss burning topics related to the SIG objective.

Examples of topics that we would like to explore:

  • Increase the awareness of researchers and KTOs in the bench-to-bedside process (maturation, clinical, regulatory, identification of a relevant need).
  • Increase the attractivity of early-stage research to investors.
  • Transition research from preclinical to clinical.
  • Train researchers and KTOs to interact and negotiate with pharma and VCs.
  • Increase the sustainability of biotech/Pharma practices by drug repurposing and use of natural products.

A subset of members of the BioMed SIG would like to create a group of stakeholders active in those fields to:

  • Identify main opportunities and challenges.
  • Generate guidelines (legal, IP, preclinical, regulatory) to be used as a reference.
  • Connect stakeholders with complementary needs to foster new collaborations.
SIG Guide

How to initiate a SIG?

Do you have a specialist interest, a burning issue, or a brilliant insight which you would like to share with the ASTP community? This guide book explains how you can initiate a Special Interest Group (SIG) with the help of HQ and your ASTP colleagues.

Testimonials

testimonial

I thought that this was an excellent introduction to the topic of Venture Capital for early-stage tech startups (and the interface with TT). The calibre of the lecturers was excellent. They were all approachable, knowledgeable, and happy to engage with the participants.

The topics covered were broad and pitched at the correct level.

Dr Alastair Cunningham, Spain

Venture Capital TC

testimonial

This is my first experience of this kind and ASTP was far beyond expectations. I really have no words. I feel much richer in soul and intellect. I wanted and still want to evolve, to learn. Even if I still have to learn, my colleagues and trainers have been exceptional.

Maria Spiridon, Romania

Building KTO for

testimonial

Left a little piece of my heart in Latvia this past week at the ASTP course for Creating Successful Spin-outs in Riga. I'm grateful to the wonderful ASTP staff for a fantastic programme.

I value these programmes for the knowledge transferred and especially for the connections made. The training days are long and intense, but as they say in Italian, vale la pena. We emerge with a better understanding and appreciation for the work we do, which in turn helps us to be more active, engaged, and generous within our respective ecosystems.

Arendt Speser, Italy

CSS

testimonial

Many thanks to ASTP for bringing your wonderful training events to Riga! I learnt a lot about early-stage technologies and their transfer via Spin-outs. It was lovely to meet friends and colleagues from previous ASTP events.

We discussed how the knowledge transfer processes are organised at our institutions and about the team effort that goes in to supporting academic inventions together with researchers.

Anna Stikane

Latvia

testimonial

It has been three intense training days and an insightful experience of learning and connecting with knowledge transfer professionals across Europe.

Thank you for providing us with such a high-quality training experience on Spin-outs!

Faye Orfanou, Greece